Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) announced its financial results for the second quarter ended June 30, 2021 as revenue jumped 122.8% to $210.0 million over last year and had a sequential increase of 17.7%. Cresco’s revenue was split almost evenly between wholesale revenue of $108.7 million and retail revenue of $101.3 million from 33 stores, an increase of 22.3% quarter-over-quarter and 157.6% year-over-year. Cresco also delivered a net income of $2.7 million, an increase of $26.8 million quarter-over-quarter and $44.4 million year-over-year.
Cresco did reaffirm its previous revenue guidance for $1 billion by the end of 2021. The company also forecast gross profit margins in excess of 50% in the remaining two quarters of 2021. It is estimating an adjusted EBITDA margin run rate of at least 30% by the end of 2021.
The company also burned through quite a bit of cash during the quarter. Cresco ended the first quarter with $258 million in cash and cash equivalents. The second quarter saw that figure drop to $135 million as cash dropped by $123 million.
“Q2 was a strong quarter of head-down execution at Cresco Labs and once again we are hitting our stride as we enter the next phase of growth. During the quarter we continued to invest in infrastructure, operationalized new assets, and deployed our proven playbook to build top positions in the most important U.S. cannabis markets,” said Charles Bachtell, Co-Founder and CEO of Cresco Labs. “We are very proud of the record performance this quarter, driven primarily by organic growth, and we’re even more excited about what lies ahead as we begin recognizing contributions from growth initiatives initiated over the last 18 months. We remain dedicated to our differentiated strategy and continue to lay the foundation for long-term leadership in the U.S. cannabis industry.”
Cresco also announced that it upsized its senior secured term loan to $400 million. The Senior Loan bears interest at a reduced rate of 9.5% per annum, with a maturity date of August 12, 2026. The company said it plans to use the money from the Senior Loan to retire its existing $200 million credit facility, fund capital expenditures, and pursue other targeted growth initiatives within the U.S. cannabis sector. The Senior Loan does not include any equity or convertible components and the total facility amount is being provided by a syndicate of five existing, institutional lenders.
Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and are made up of brands including Cresco, Cresco Reserve, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education, and convenience for both existing and new cannabis consumers.